1) Omic Orthogonal

Glyco-as-a-Complement (GaaC) to DNA / RNA based assays

Learn more

2) Treatments And Patients

Enabling better therapy choice and response monitoring

Learn more

3) Targets And Molecules

Discovering new novel glycosylated targets

Learn more

InterVenn is committed to understanding diseases, through the interdependence of various disciplines, always with patient care at the core.

Learn More About Our Core Technology »